These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9576433)
1. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Myerburg RJ; Mitrani R; Interian A; Castellanos A Circulation; 1998 Apr; 97(15):1514-21. PubMed ID: 9576433 [No Abstract] [Full Text] [Related]
2. Statistical problems in the design of antiarrhythmic drug trials. Friedman LM; Schron EB J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S114-8. PubMed ID: 1279303 [TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study]. Meinertz T; Zehender M; Hohnloser SH Z Kardiol; 1992; 81 Suppl 4():145-9. PubMed ID: 1290291 [TBL] [Abstract][Full Text] [Related]
4. [Protocol-guide in clinical experimentation on anti-arrhythmia agents]. Tavazzi L; Sanna GP; Tognoni G; Rizzon P G Ital Cardiol; 1985 Jul; 15(7):711-7. PubMed ID: 4076706 [No Abstract] [Full Text] [Related]
5. Antiarrhythmic drug trials: what lessons have we learned? Gambhir DS; Batra R Indian Heart J; 1997; 49(4):435-8. PubMed ID: 9358675 [No Abstract] [Full Text] [Related]
6. Clinical trials in the evaluation of antiarrhythmic drugs: design, drugs, and double-blind considerations. Moss AJ Ann N Y Acad Sci; 1984; 432():103-7. PubMed ID: 6395754 [No Abstract] [Full Text] [Related]
11. [Prevention of sudden death with antiarrhythmic agents after myocardial infarction]. Raviele A; Gasparini G G Ital Cardiol; 1992 Apr; 22(4):463-7. PubMed ID: 1385246 [No Abstract] [Full Text] [Related]
12. [Perspectives in anti-arrhythmia pharmacological therapy]. Furlanello F; Vergara G; Inama G; Dal Forno P; Bettini R; Disertori M Cardiologia; 1984; 29(1-2):73-84. PubMed ID: 6442869 [No Abstract] [Full Text] [Related]
13. [Clinical experience with the antiarrhythmic propafenone (Rytmonorm)]. Stejfa M; Spác J; Vítovec J; Havlát F Vnitr Lek; 1986 Apr; 32(4):393-7. PubMed ID: 3523975 [No Abstract] [Full Text] [Related]
14. The assessment of antidysrhythmic drugs. Levitt B J Clin Pharmacol; 1984 Jul; 24(7):328-32. PubMed ID: 6384278 [TBL] [Abstract][Full Text] [Related]
15. [Antiarrhythmic drug allapinin: review of results of clinical investigation]. Sokolov SF; Dzhakhangirov FN Kardiologiia; 2002; 42(7):96-102. PubMed ID: 12494120 [TBL] [Abstract][Full Text] [Related]
17. Will antiarrhythmic drug therapy guided by electrophysiology study survive in the new millennium? Lazzara R J Cardiovasc Pharmacol Ther; 2001 Jan; 6(1):1-4. PubMed ID: 11452331 [No Abstract] [Full Text] [Related]
18. Clinical evaluation of the efficacy of antiarrhythmic drugs. Campbell RW Cardiologia; 1983 Sep; 28(9):739-46. PubMed ID: 6398702 [No Abstract] [Full Text] [Related]
19. Evaluation of antiarrhythmic drugs by sudden death trials. Fisher LD Circulation; 1986 Feb; 73(2 Pt 2):II98-100. PubMed ID: 3510770 [No Abstract] [Full Text] [Related]
20. Effect of age on antiarrhythmic drug efficacy and toxicity. Podrid PJ; Levine PA; Klein MP Am J Cardiol; 1989 Mar; 63(11):735-9. PubMed ID: 2646900 [No Abstract] [Full Text] [Related] [Next] [New Search]